Blood pressure goals in type 2 diabetes-assessing the evidence
Lancet Diabetes Endocrinol
.
2017 May;5(5):319-321.
doi: 10.1016/S2213-8587(17)30035-9.
Epub 2017 Feb 4.
Authors
Peter M Nilsson
1
,
Sverre E Kjeldsen
2
Affiliations
1
Department of Clinical Sciences, Lund University, Skåne University Hospital, S-20502 Malmö, Sweden. Electronic address: peter.nilsson@med.lu.se.
2
Department of Cardiology, University of Oslo, Ullevaal University Hospital, Oslo, Norway.
PMID:
28169174
DOI:
10.1016/S2213-8587(17)30035-9
No abstract available
MeSH terms
Antihypertensive Agents / therapeutic use*
Blood Pressure*
Diabetes Mellitus, Type 2 / complications*
Humans
Hypertension / drug therapy*
Hypertension / etiology
Observational Studies as Topic
Substances
Antihypertensive Agents